Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
Analyst, antitussive, authentification, batch, billing, built, Capsugel, CERC, Cerecor, chlorpheniramine, climate, coated, codeine, CODM, cold, collateralized, commensurate, complimentary, constraint, cough, cultivation, deferral, derecognized, destination, DQSA, eighteen, endocrinology, evidenced, expedient, eye, EYEG, EyeGate, facilitate, farther, hedge, HPG, Ketan, Leasehold, LiquiXR, lot, Maker, McKinsey, Mehta, mentioned, modestly, Moran, narrative, nineteen, nonrecurring, Oklahoma, passed, paydown, Pennsylvania, Pfizer, pharmacist, piece, Plante, PLLC, polistirex, prefund, renegotiate, renegotiated, resin, retire, retroactively, SAB, scientist, Senator, shorter, stream, thew, tied, Title, transparency, turnover, Tuzistra, verification, viewed, waived, Wharton, whichever, wholsaler, XR, ZolpiMistTM
Removed:
abbreviated, abide, abnormal, abnormally, absent, academia, accommodate, accredited, accretive, acid, acne, acquiree, acute, addressed, adjunct, adult, affix, affixed, afforded, Africa, age, aged, agglutination, alcohol, analog, analytical, analyzer, ANDA, Androderm, androgen, andrology, animal, antigen, applicant, applicator, area, arm, Asia, Asian, aspect, assistance, assisted, atrophy, attached, audible, auditing, automatically, Axiron, backlight, bankruptcy, battery, bilateral, bilirubin, bioavailability, biocompatible, bioequivalence, biologic, body, bolstered, bone, boost, born, bound, Bulk, calculate, called, capable, capacitance, capromab, carotene, catalase, Caucasian, Cavg, Cdn, cell, cellular, ceramic, cerebrospinal, certification, certify, cessation, challenge, characterized, chemotherapy, child, chronic, circuit, cited, claiming, clarify, classically, classification, Cleveland, clinic, Cmax, cognitive, cohort, collected, commencing, committed, communication, comparatively, comparing, comparison, complexity, complication, composed, concentrating, concentration, concept, concurrently, configuration, configured, confirmation, confirmed, conform, congenital, connected, connector, consecutive, construct, contraindicated, contrast, converter, correct, correlate, correlated, correlation, Council, count, cryptorchidism, crystal, cumbersome, custom, customary, cutoff, cycle, CYDY, CytoDyn, decided, deficiency, deficient, define, depletion, depreciated, depressive, dermal, desire, desktop, detect, determinable, diagnosing, dietary, digital, diminished, directing, Directive, dismutase, disposable, distinctly, diversify, divided, DNA, domain, dominate, dosage, dose, doubtful, download, DPDT, driver, easier, Eastern, EC, economically, ED, edition, EEA, ejaculate, electrochemical, electrode, enabled, enactment, encouraging, Endo, endpoint, energy, entering, envision, equilibrium, equipped, equivalence, equivalent, erectile, essential, ETASU, ethical, EU, examine, excessive, exempt, exempted, exemption, exploratory, exposure, expressed, expressly, externally, extremely, facial, FDC, fertile, filtering, fit, Flash, flexibly, fragmentation, FRAM, front, FSC, FSH, FTC, galvanostat, GCP, GLP, glutathione, goal, gonadal, gonadotropin, goodwill, guide, hair, halted, harming, header, healthy, heavy, hydrogen, hydroxyl, hyperandrogenism, Hypogonadotropic, Iceland, IDE, imbalance, impacting, impedance, implantable, implemented, importance, Importantly, importing, impossible, impractical, inadvertent, incidence, incomplete, inconvenience, India, infection, influential, informed, inInternal, injection, innovator, inserted, inspect, instructed, integral, integrity, interface, intermediate, intimate, intranasally, introduce, introducing, invalid, invalidity, invasive, ion, IRB, irritability, ITT, jack, Jazz, Klinefelter, labeled, laboratory, Lastly, LCD, left, legally, lessee, lethargy, leukocytospermia, leverage, LH, LHRH, libido, Liechtenstein, lightweight, Lincoln, linked, liquefaction, list, LOCF, luteinizing, lycopene, margin, mark, markdown, marker, marketable, markup, masculine, mechanical, mechanism, medication, membrane, met, metabolism, metal, mg, MHz, microscopic, middle, minimize, ml, mode, moderately, modest, modification, modify, moiety, molecule, morning, morphology, motile, motility, mounted, mucosa, multicenter, muscle, nasally, NCE, necessitate, newly, Ninety, nitric, nominal, nonclinical, Norway, noted, notified, novelty, observation, older, onset, optimal, orchiectomy, ordering, orientation, originally, originating, Orphan, OTCQB, OTCQX, outpatient, overhead, oxidation, oxide, oxygen, Pacific, pain, panel, Paragraph, Park, pathway, pattern, payout, PC, peer, pendetide, penetration, performed, permanent, permission, peroxidase, peroxide, peroxynitrite, persuasive, pharmacokinetic, pharmacology, Phase, Physiology, pipeline, pivotal, play, PLL, point, poor, powered, preceding, predecessor, predetermined, predicate, preliminary, preparing, priced, programmed, progressive, proliferation, prolonged, prominent, proof, proportional, PSA, puberty, published, punitive, pure, quantitative, quickly, radiation, radical, reached, reactive, reader, readily, reagent, Receiver, recertification, reconsider, recoverability, recovery, recruited, recurrent, redox, referenced, reflecting, register, regularity, regulating, relation, rental, repeat, reproducibility, resale, resubmission, resulted, retail, revocation, robust, ROC, root, ROS, ROU, route, routine, routinely, scalp, SD, secondarily, secondary, secretion, select, SEM, send, sensitivity, separated, sequential, serial, serum, sexually, shareholder, show, showed, showing, sildenafil, simple, simply, slightly, smoking, snapshot, Society, SOD, South, Spearman, specificity, specimen, SPI, stability, standardization, standardized, sterile, strategically, strength, strongly, studied, studying, submitting, substituted, substrate, suffering, suited, superoxide, supplementation, supplied, surgery, suspected, sustaining, switch, syndrome, tangible, targeted, taxing, taxpayer, temperature, testicular, therapeutically, threshold, tissue, tocopherol, tolerance, tolerate, topical, Toronto, torsion, torso, toxicity, tract, traditional, transferred, transport, Transportation, trauma, treated, trimethoprim, TRLLC, TSA, type, underdiagnosed, undertaken, undervalued, underwent, unintentional, uniquely, unreasonable, updated, uric, urologic, USB, user, utilizing, validated, vanishing, vigilance, visible, vitamin, volatility, white, wholly, yearly, yield, younger
Filing tables
Filing exhibits
- 10-K Annual report
- 23.1 Consent of Plante & Moran, PLCC, Independent Registered Public Accounting Firm
- 23.2 Consent of Eks&h LLLP, Independent Registered Public Accounting Firm
- 31 Certification Pursuant to Rule 13A-14(A)/15D-14(A) Certifications Section 302 of the Sarbanes-oxly Act of 2002
- 31.2 Certification Pursuant to Rule 13A-14(A)/15D-14(A) Certifications Section 302 of the Sarbanes-oxly Act of 2002
- 32.1 Certificate Pursuant to Section 18 U.s.c. Pursuant to Section 906 of the Sarbanes-oxley Act of 2002
- Download Excel data file
- View Excel data file
Related press release
AYTU similar filings
Filing view
External links
Exhibit 32.1
CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
PURSUANT TO 18 U.S. C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the annual report on Form 10-K of Aytu BioScience, Inc. (the “Company”) for the fiscal year ended June 30, 2019, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of Joshua R. Disbrow, Chief Executive Officer (Principal Executive Officer), and David A. Green, Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer), of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge:
(1)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: September 26, 2019 | /s/ Joshua R. Disbrow | ||
Joshua R. Disbrow | |||
Chief Executive Officer (Principal Executive Officer) |
Dated: September 26, 2019 | /s/ David A. Green | ||
David A. Green | |||
Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) |